Category Archives: Uncategorized

Biostatistics Services

Makrocare clinical Biostatistics services provide clients with integrated, therapeutically aligned programs for planning, execution, & analysis across all phases. MakroCare biostatistics and statistical programming services include pre-analysis, analysis, and post-analysis Read More Advertisements

Posted in Uncategorized | Leave a comment

Webinar on Risk Management EU MDR Perspective

Risk management is understood as a continuous iterative process throughout the entire life cycle of a device, requiring regular systematic updating. Though Risk management has been a requirement in MDD also, EU MDR places greater emphasize on this area. EU … Continue reading

Posted in EU MDR, Medical Device, Medical Device Webinar, Pharmaceutical, Uncategorized, Webinar on Medical Device, Webinar on Risk Management, Webinars | Tagged , , , , , , , , , , | Leave a comment

Webinar on Importance & Requirements of Clinical Evaluation for CER

The revised guidance MEDDEV 2.7/1 rev 4 reveals a course of changes to a more prescriptive and demanding set of expectations. A sound ongoing procedure to collect, appraise and analyse clinical data pertaining to a medical device and to evaluate … Continue reading

Posted in CER Webinar, Clinical Evaluation Webinar, Uncategorized | Tagged , , , , , , , , | Leave a comment

Webinar on Growing need of Clinical Data, PMCF & Registries for Devices

  Post Market Clinical Follow Up (PMCF) studies are a critical component of the clinical evidence required to comply with the new European regulations. As Clinical Evidence Reports (CERs) encounter more and more scrutiny by Notified Bodies (NBs), the gaps … Continue reading

Posted in PMCF & Registry Webinar, Uncategorized | Tagged , , , , , , , , , , , , , , | Leave a comment

Webinar on Matured/Established Products Regulatory Support & Models

Matured products go through multiple decisions in Global organization like: Keep or divest? Same teams or different teams to handle them? For regional support, who should pay? and more. All these stemming from cost pressures in global markets and changing … Continue reading

Posted in Regulatory Support, Uncategorized | Tagged , , , | Leave a comment